Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Trends in Hepatocellular Carcinoma Incidence and Risk Among Persons With HIV in the US and Canada, 1996-2015
Jing Sun, Keri N. Althoff, Yuezhou Jing, et al.
JAMA Network Open (2021) Vol. 4, Iss. 2, pp. e2037512-e2037512
Open Access | Times Cited: 44

Showing 1-25 of 44 citing articles:

Hepatocellular carcinoma
Arndt Vogel, Tim Meyer, Gonzalo Sapisochín, et al.
The Lancet (2022) Vol. 400, Iss. 10360, pp. 1345-1362
Closed Access | Times Cited: 1394
Global burden of liver disease: 2023 update
Harshad Devarbhavi, Sumeet K. Asrani, Juan Pablo Arab, et al.
Journal of Hepatology (2023) Vol. 79, Iss. 2, pp. 516-537
Open Access | Times Cited: 922
Hepatobiliary Cancers, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology
Al B. Benson, Michael I. D’Angelica, Daniel E. Abbott, et al.
Journal of the National Comprehensive Cancer Network (2021) Vol. 19, Iss. 5, pp. 541-565
Open Access | Times Cited: 743
Incidence and mortality of non-AIDS-defining cancers among people living with HIV: A systematic review and meta-analysis
Tanwei Yuan, Yuqing Hu, Xinyi Zhou, et al.
EClinicalMedicine (2022) Vol. 52, pp. 101613-101613
Open Access | Times Cited: 70
Lifestyle modification programme for people living with HIV with metabolic dysfunction-associated steatotic liver disease: a randomised controlled trial
G. Li, Vincent Wai-Sun Wong, Ruth Chan, et al.
The Lancet HIV (2025)
Closed Access | Times Cited: 1
Hepatocellular carcinoma: measures to improve the outlook in sub-Saharan Africa
C Wendy Spearman, Geoffrey Dusheiko, Eduard Jonas, et al.
˜The œLancet. Gastroenterology & hepatology (2022) Vol. 7, Iss. 11, pp. 1036-1048
Closed Access | Times Cited: 26
Epidemiological characteristics and precise prophylaxis and control of HBV-associated primary liver cancer
Yuqi Feng, Letian Fang, Guangwen Cao
Hepatoma Research (2025)
Open Access
Impact of HIV Infection on Hepatocellular Carcinoma: A Long-Term Prognostic Analysis
Yuhang Diao, Fengxia Gong, Yong Cheng
Journal of Laparoendoscopic & Advanced Surgical Techniques (2025) Vol. 35, Iss. 2, pp. 109-117
Closed Access
Tumor protein 53 gene polymorphism, demographic attributes and associated risk factors among liver cancer patients in Calabar, Nigeria
Blessing B Ekpenyong, Godwin Michael Ubi, MaryEsien Kooffreh, et al.
BMC Cancer (2025) Vol. 25, Iss. 1
Open Access
Evaluating Challenges in Access To Transplantation for Persons with HIV
Ruth O Adekunle, Moreno S. Rodrigues, Christine M. Durand
Current HIV/AIDS Reports (2025) Vol. 22, Iss. 1
Open Access
Racial disparities in cancer risk among MSM with HIV in the United States
B.S. Meldrum, Jennifer K. McGee‐Avila, Qianlai Luo, et al.
AIDS (2025) Vol. 39, Iss. 6, pp. 728-736
Closed Access
Hepatocellular carcinoma in people living with HIV
Claudia Angela Maria Fulgenzi, Alessia Dalla Pria, Alberto Giovanni Leone, et al.
Journal of Hepatology (2025)
Open Access
HIV-HBV Coinfection—Current Challenges for Virologic Monitoring
Simona Ruță, Laura Iulia Grecu, Diana Gabriela Iacob, et al.
Biomedicines (2023) Vol. 11, Iss. 5, pp. 1306-1306
Open Access | Times Cited: 9
A nationwide cross-sectional review of in-hospital hepatitis B virus testing and disease burden estimation in Ghana, 2016 - 2021
Yvonne Ayerki Nartey, Rafiq Okine, Atsu Seake-Kwawu, et al.
BMC Public Health (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 13
Cancer screening in people living with HIV
Mar Masiá, Ana Gutiérrez‐Ortiz de la Tabla, Félix Gutiérrez
Cancer Medicine (2023) Vol. 12, Iss. 21, pp. 20590-20603
Open Access | Times Cited: 8
Risk of hepatocellular carcinoma in people with HIV in the United States, 2001-2019
Jennifer K. McGee‐Avila, Ilona Argirion, Eric A. Engels, et al.
JNCI Journal of the National Cancer Institute (2023) Vol. 116, Iss. 1, pp. 61-68
Open Access | Times Cited: 7
A novel disulfidptosis-related lncRNAs signature for predicting survival and immune response in hepatocellular carcinoma
Zhoubo Guo, Yan Xie, Li Zhang, et al.
Aging (2024)
Open Access | Times Cited: 2
Mutational signatures and processes in hepatobiliary cancers
Ekaterina Zhuravleva, Colm J. O’Rourke, Jesper B. Andersen
Nature Reviews Gastroenterology & Hepatology (2022) Vol. 19, Iss. 6, pp. 367-382
Closed Access | Times Cited: 11
Human Immunodeficiency Virus
Kimberly Bates, Megan Brundrett
Springer eBooks (2024), pp. 435-459
Closed Access | Times Cited: 2
HIV and liver disease: a comprehensive update.
Kenneth E. Sherman, David L. Thomas
PubMed (2022) Vol. 30, Iss. 4, pp. 547-558
Closed Access | Times Cited: 10
Prediction of hepatocellular carcinoma risk in patients with type-2 diabetes using supervised machine learning classification model
Noor Atika Azit, Shahnorbanun Sahran, Voon Meng Leow, et al.
Heliyon (2022) Vol. 8, Iss. 10, pp. e10772-e10772
Open Access | Times Cited: 9
Incidence of hepatocellular carcinoma and mortality in chronic viral hepatitis in an Asian population with and without HIV infection
Grace Lui, Vicki Wing‐Ki Hui, Shun‐Fung Sze, et al.
Alimentary Pharmacology & Therapeutics (2023) Vol. 58, Iss. 8, pp. 814-823
Closed Access | Times Cited: 5
Serum protein biomarkers for HCC risk prediction in HIV/HBV co-infected people: a clinical proteomic study using mass spectrometry
Hengning Ke, Yuan Rui, Huan Liu, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 5
HBV Infection-Related PDZK1 Plays an Oncogenic Role by Regulating the PI3K-Akt Pathway and Fatty Acid Metabolism and Enhances Immunosuppression
Xin Chen, Xiaodong Wang, Feng Zhu, et al.
Journal of Immunology Research (2022) Vol. 2022, pp. 1-18
Open Access | Times Cited: 7
Tenofovir use is associated with a decreased risk of hepatocellular carcinoma among men with HIV irrespective of coinfection status
Mei‐Hsuan Lee, Ping-Feng Wu, Tzu-I Chen, et al.
JHEP Reports (2022) Vol. 5, Iss. 3, pp. 100634-100634
Open Access | Times Cited: 7
Page 1 - Next Page

Scroll to top